JI-101

· Jubilant Innovation Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for JI-101, covering 2013-06-24 to 2014-09-25. Get the full timeline:

Most recent: Clinical Trial Update: Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers [Phase 1, Phase 2]

See pricing